Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer
ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-120
SponsorOmphis Foundation
About this trial
The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.
Eligibility criteria
Qualifiers
Patients >18 years of age with breast cancer who are candidates for sentinel lymph node detection will be included.
N0 patients or patients who have undergone target axillary detection with good response
Disqualifiers
Lymphadenectomy
Trial design
Treatments tested in this trial
- Application of green indocyanine colorant
- Technetium99
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov